Thomas Goralski
Directeur des opérations chez Expression Analysis, Inc.
Postes actifs de Thomas Goralski
Sociétés | Poste | Début | Fin |
---|---|---|---|
Expression Analysis, Inc.
Expression Analysis, Inc. Medical SpecialtiesHealth Technology Expression Analysis, Inc. supplies microarray services and solutions for clinical trials. It provides experimental design consultation, biologic sample preparation, sample processing, and statistical analysis services. The company was founded in September, 2001 by Steven Casey and is headquartered in Durham, NC. | Directeur des opérations | - | - |
Historique de carrière de Thomas Goralski
Anciens postes connus de Thomas Goralski
Sociétés | Poste | Début | Fin |
---|---|---|---|
Incyte Genomics Inc. /Micoarray Operations/ | Corporate Officer/Principal | - | - |
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 2 |
Retail Trade | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Expression Analysis, Inc.
Expression Analysis, Inc. Medical SpecialtiesHealth Technology Expression Analysis, Inc. supplies microarray services and solutions for clinical trials. It provides experimental design consultation, biologic sample preparation, sample processing, and statistical analysis services. The company was founded in September, 2001 by Steven Casey and is headquartered in Durham, NC. | Health Technology |
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
Incyte Genomics Inc. /Micoarray Operations/ | Commercial Services |
- Bourse
- Insiders
- Thomas Goralski
- Expérience